Endoscopic sclerotherapy is a non-surgical treatment performed through an endoscope. It can help stop active variceal bleeding, so it is useful in emergencies. It also treats a serious complication of portal hypertension. How well it works depends on your liver condition and how your body responds.
Like any procedure, sclerotherapy has risks. Common risks include chest pain, trouble swallowing, ulcers in the esophagus, and bleeding. Esophageal perforation, a tear in the esophagus, is rare. Your healthcare team will talk with you about benefits and risks before treatment and will watch you closely afterward.
For most people with bleeding esophageal varices, EVL is preferred over sclerotherapy. It is linked to better initial control of bleeding, lower rates of rebleeding, and fewer adverse events.